Professor Aimin Xu (third from left) and his team at the Hong Kong Science Park, where their start-up is located. ImmunoDiagnostics Ltd was set up last year to facilitate the licensing and commercialisation of the biomarker discoveries of Professor Aimin Xu’s team.
